ASX 300

The Hyperion team recently hosted a webinar discussing how they are seeing markets and some of the stocks in the portfolios.

In part two of the series, we investigate the 8 most prospective ASX silver stocks including ARD, ADT, BML, IVR, MMC, SVL, SS1 & USL.

We look at five of the biggest developments across global markets for the week ending 17 May 2024

Plus, EQ gets a helping government hand for tungsten project and is Canadian lithium explorer Patriot in play?

In this episode, Livewire's Chris Conway sits down with two experts for their analysis of the small-cap market's darlings and dogs.

Why we see significant upside in this Aussie industrial icon

In this wire, Auscap's Tim Carleton shares why the firm has decided to launch an ASX Ex-20 Fund.

In this Part 1 of a 2 part series, we investigate the demand and supply factors for silver to determine if its price can continue to rise.

What an insight! Love of geology, hard work, the hunt for gold, team work, passion-driven leadership and building a company.

Get up to date on overnight market activity and the big events for the day.

Callum Newman of Fat Tail Investment Research explains how he uses algorithms to detect stress, risk and trades in the market

And the other highlights investors need to know.

Plus, why investors should focus on getting rich slowly.

Get up to date on overnight market activity and the big events for the day.

We investigate the burning questions on Aussie bank investors’ minds! Which has the best dividend yield? Which is the cheapest? And more...

The 10 most interesting stocks that major broker Citi has highlighted for their most attractive (and unattractive) qualities.

Get up to date on overnight market activity and the big events for the day.

SiteMinder is one of a few small-cap software companies with the potential to deliver the prized ‘Rule-of-40’ metrics.

Shareholders of ResMed (ASX: RMD) have been on a rollercoaster ride in the past year. Late last year, after news of the efficacy of Ozempic and other GLP-1 drugs came...

Listen to Take Stock with Raphael Lamm, L1 Capital

It has been a while since we reported on the major banks, which have now all provided half-year updates to their operating performance.

In today’s ROCast Murdoch sits down with Andrew Mitchell Co-Founder at Ophir Asset Management to discuss outlook, TMDX, Life360 & more.

With the healthcare sector in a deep and prolonged downturn, valuations of public and private R&D stage companies are very attractive.

In this episode, OC Funds Management's Aaron Yeoh and Datt Capital's Emanuel Datt share their tips and tricks for identifying growth stocks.